McBride John S. 4
4 · Novus Therapeutics, Inc. · Filed Jul 15, 2019
Insider Transaction Report
Form 4
McBride John S.
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-07-11+20,000→ 20,000 totalExercise: $0.88From: 2020-07-11Exp: 2029-07-11→ Common Stock (20,000 underlying)